Efficacy and safety outcomes according to iodixanol versus LOCM use
| Iodixanol (No.) (%) | LOCM (No.) (%) | Absolute % Risk Difference | Relative % Difference | |
|---|---|---|---|---|
| N | 31 | 102 | – | – |
| mTICI 2b/3 | 16 (51.6) | 42 (41.2) | 10.4 | 20.2 |
| mRS 0–2 | 11 (35.5) | 31 (30.4) | 5.1 | 14.4 |
| AICH | 9 (29.0) | 42 (41.2) | −12.1 | −29.6 |
| SICH | 2 (6.5) | 9 (8.8) | −2.4 | −26.1 |
| Mortality | 6 (19.4) | 26 (25.5) | −6.1 | −23.9 |
Note:—AICH indicates asymptomatic ICH.